In a previous study, we found that the presence of the NPM1 gene mutation was negatively associated with the susceptibility of FLT3-ITD AML cells to the FLT3 inhibitor midostaurin and the MDM2 inhibitor NVP-HDM201 [41]. Here, MDM2 is linked to acute myeloid leukemia.